Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tulasi Yadati

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cells|July 17, 2020
<i>The Ins and Outs of Cathepsins</i>: Physiological Function and Role in Disease ManagementTulasi Yadati, Tom Houben, Albert Bitorina, et al.
Cells|July 3, 2019
Inflammatory Bowel Disease: A Stressed "Gut/Feeling"Yvonne Oligschlaeger, Tulasi Yadati, Tom Houben, et al.
Biomolecules|May 8, 2019
Inhibiting Extracellular Cathepsin D Reduces Hepatic Steatosis in Sprague⁻Dawley Rats <sup>†</sup>Princy Khurana, Tulasi Yadati, Sandeep Goyal, et al.
Journal of the American Heart Association|September 8, 2021
Cysteamine Decreases Low-Density Lipoprotein Oxidation, Causes Regression of Atherosclerosis, and Improves Liver and Muscle Function in Low-Density Lipoprotein Receptor-Deficient MiceFeroz Ahmad, Robert D Mitchell, Tom Houben, et al.
Journal of Cancer|September 3, 2021
OxLDL as an Inducer of a Metabolic Shift in Cancer CellsAlbert V Bitorina, Yvonne Oligschlaeger, Lingling Ding, et al.
Frontiers in Immunology|August 2, 2021
Inhibition of Extracellular Cathepsin D Reduces Hepatic Lipid Accumulation and Leads to Mild Changes in Inflammationin NASH MiceTulasi Yadati, Tom Houben, Albert Bitorina, et al.
Frontiers in Immunology|September 7, 2021
Pro-Inflammatory Implications of 2-Hydroxypropyl-β-cyclodextrin TreatmentTom Houben, Tulasi Yadati, Robbin de Kruijf, et al.
The FEBS Journal|December 27, 2024
Inhibition of intracellular versus extracellular cathepsin D differentially alters the liver lipidome of mice with metabolic dysfunction-associated steatohepatitisIsabeau Vermeulen, Mengying Li, Hester van Mourik, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cells|July 17, 2020
<i>The Ins and Outs of Cathepsins</i>: Physiological Function and Role in Disease ManagementTulasi Yadati, Tom Houben, Albert Bitorina, et al.
Cells|July 3, 2019
Inflammatory Bowel Disease: A Stressed "Gut/Feeling"Yvonne Oligschlaeger, Tulasi Yadati, Tom Houben, et al.
Biomolecules|May 8, 2019
Inhibiting Extracellular Cathepsin D Reduces Hepatic Steatosis in Sprague⁻Dawley Rats <sup>†</sup>Princy Khurana, Tulasi Yadati, Sandeep Goyal, et al.
Journal of the American Heart Association|September 8, 2021
Cysteamine Decreases Low-Density Lipoprotein Oxidation, Causes Regression of Atherosclerosis, and Improves Liver and Muscle Function in Low-Density Lipoprotein Receptor-Deficient MiceFeroz Ahmad, Robert D Mitchell, Tom Houben, et al.
Journal of Cancer|September 3, 2021
OxLDL as an Inducer of a Metabolic Shift in Cancer CellsAlbert V Bitorina, Yvonne Oligschlaeger, Lingling Ding, et al.
Frontiers in Immunology|August 2, 2021
Inhibition of Extracellular Cathepsin D Reduces Hepatic Lipid Accumulation and Leads to Mild Changes in Inflammationin NASH MiceTulasi Yadati, Tom Houben, Albert Bitorina, et al.
Frontiers in Immunology|September 7, 2021
Pro-Inflammatory Implications of 2-Hydroxypropyl-β-cyclodextrin TreatmentTom Houben, Tulasi Yadati, Robbin de Kruijf, et al.
The FEBS Journal|December 27, 2024
Inhibition of intracellular versus extracellular cathepsin D differentially alters the liver lipidome of mice with metabolic dysfunction-associated steatohepatitisIsabeau Vermeulen, Mengying Li, Hester van Mourik, et al.
Pageof 1